Results for tag: "Fenpiverinium"

Fenpiverinium is a type of gastrointestinal drug used to treat symptoms of irritable bowel syndrome (IBS). It is a muscarinic receptor antagonist, meaning it blocks the action of the neurotransmitter acetylcholine, which is responsible for the contraction of smooth muscle in the gastrointestinal tract. This helps to reduce the symptoms of IBS, such as abdominal pain, bloating, and constipation. Fenpiverinium is available in both oral and injectable forms, and is often used in combination with other medications to treat IBS. Fenpiverinium is a relatively new drug, and is not yet widely available. It is currently approved for use in the United States, Canada, and Europe, but is not yet approved in other countries. As such, the market for fenpiverinium is still relatively small. Some companies in the fenpiverinium market include Merck, Pfizer, and Novartis. These companies are involved in the research, development, and marketing of fenpiverinium. Other companies, such as Teva Pharmaceuticals and Mylan, are also involved in the production and distribution of the drug. Show Less Read more